Drosophila melanogaster as a Model Organism for Invasive Aspergillosis
Mammalian hosts have traditionally been considered the “gold standard” models for studying pathogenesis and antifungal drug activity in invasive aspergillosis (IA). Nevertheless, logistical, economical, and ethical constraints make these host systems difficult to use for high-throughput screening of putative Aspergillus virulence factors and novel antifungal compounds. Here, we present Drosophila melanogaster, a heterologous non-vertebrate host with conserved innate immunity and genetic tractability, as an alternative, easy-to-use, and inexpensive pathosystem for studying Aspergillus pathogenesis and antifungal activity. We describe three different infection protocols (i.e., injection, rolling, ingestion) that introduce Aspergillus conidia at different anatomical sites of Toll-deficient Drosophila flies. These reproducible assays can be used to (1) determine the virulence of various Aspergillus strains and to (2) assess the anti-Aspergillus activity of orally absorbed antifungal agents in vivo. These methods can also be adapted to study pathogenesis and antifungal drug activity against other medically important human fungal pathogens.
Key wordsDrosophila Fruit fly Invertebrate mini-host model Aspergillus Aspergillosis Virulence Pathogenesis Antifungal efficacy
- 1.Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100.PubMedCrossRefGoogle Scholar
- 4.Pfaller MA and Rinaldi MG (1993) Antifungal susceptibility testing. Current state of technology, limitations, and standardization. Infect Dis Clin North Am 2:435–444.Google Scholar
- 5.Lionakis MS, Lewis RE, Chamilos G and Kontoyiannis DP (2005) Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Pharmacotherapy 25:1174–1180.PubMedCrossRefGoogle Scholar
- 21.Apidianakis Y, Rahme LG, Heitman J, Ausubel FM, Calderwood SB and Mylonakis E (2004) Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response Eukaryot Cell 3:413–419.Google Scholar
- 42.Kontoyiannis DP, Lionakis MS and Halder G (2004) Toll pathway in Drosophila melanogaster: A possible role to study the impact of immune senescence in poor responses against Aspergillus fumigatus. 14th Focus on Fungal Infections, New Orleans, LA, USA, Abstract # 31.Google Scholar